Ofloxacin Ophthalmic Drops Clinical Trials

• Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops
  ClinicalTrials.gov Identifier: NCT00565630 - Not yet recruiting
  Cataract
  
• Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo
  ClinicalTrials.gov Identifier: NCT00405730 - Active, not recruiting
  Cataract Surgery
  
• TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00576251 - Recruiting
  Ocular Inflammation Associated With Blepharaconjunctivitis
  
• Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate
  ClinicalTrials.gov Identifier: NCT00480376 - Not yet recruiting
  Infection
  
• Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?
  ClinicalTrials.gov Identifier: NCT00405431 - Active, not recruiting
  Glaucoma
  
• Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
  ClinicalTrials.gov Identifier: NCT00442312 - Active, not recruiting
  Glaucoma
  
• Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567918 - Active, not recruiting
  Keratoconjunctivitis; Conjunctivitis
  
• One Hour Preoperative Gatifloxacin
  ClinicalTrials.gov Identifier: NCT00350363 - Recruiting
  Ophthalmic Surgery
  
• Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
  ClinicalTrials.gov Identifier: NCT00333060 - Active, not recruiting
  Epiretinal Membrane; Macular Hole
  
• Study of Rebamipide Eye Drops to Treat Dry Eye
  ClinicalTrials.gov Identifier: NCT00201981 - Active, not recruiting
  Keratoconjunctivitis Sicca
  
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
  ClinicalTrials.gov Identifier: NCT00370747 - Active, not recruiting
  Dry Eye Syndromes
  
• Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00424398 - Active, not recruiting
  Conjunctivitis, Allergic
  
• Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00333918 - Active, not recruiting
  Pain; Inflammation
  
• Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00423007 - Active, not recruiting
  Allergic Conjunctivitis
  
• Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00241319 - Active, not recruiting
  Allergic Conjunctivitis
  
• Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00244543 - Active, not recruiting
  Allergic Conjunctivitis
  
• Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00364091 - Active, not recruiting
  Allergic Conjunctivitis
  
• Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00475319 - Recruiting
  Dry Eye Syndromes
  
• Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00223951 - Active, not recruiting
  Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis
  
• Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
  ClinicalTrials.gov Identifier: NCT00444665 - Recruiting
  Glaucoma
  
• Evaluation and Treatment Protocol for Potential Research Participants With Inherited Ophthalmic Diseases
  ClinicalTrials.gov Identifier: NCT00559234 - Recruiting
  Cataract; Glaucoma; Retinitis Pigmentosa; Macular Degeneration; Strabismus
  
• A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.
  ClinicalTrials.gov Identifier: NCT00463320 - Recruiting
  Age-Related Macular Degeneration
  
• Cross-Over Evaluation of Two Lubricating Eye Drops
  ClinicalTrials.gov Identifier: NCT00493662 - Recruiting
  Dry Eye
  
• Repository for Inherited Eye Diseases
  ClinicalTrials.gov Identifier: NCT00378742 - Recruiting
  Retinitis Pigmentosa; Inherited Ophthalmic Diseases
  
• Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00002850 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection
  
• Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients with Dry Eye
  ClinicalTrials.gov Identifier: NCT00037661 - Completed
  Keratoconjunctivitis Sicca
  
• Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.
  ClinicalTrials.gov Identifier: NCT00440336 - Recruiting
  Open Angle Glaucoma
  
• "Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer
  ClinicalTrials.gov Identifier: NCT00338481 - Recruiting
  Dyspnea; Lung Neoplasms
  
• Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
  ClinicalTrials.gov Identifier: NCT00491166 - Recruiting
  Diabetic Macular Edema
  
• Comparison of CL Wear Between Two Allergy Drops
  ClinicalTrials.gov Identifier: NCT00489398 - Not yet recruiting
  Allergic Conjunctivitis
  
• Study to Determine if Taking an Over The Counter Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Eye Drops for the Treatment of Glaucoma
  ClinicalTrials.gov Identifier: NCT00402493 - Recruiting
  Glaucoma; Ocular Hypertension
  
• Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
  ClinicalTrials.gov Identifier: NCT00443924 - Recruiting
  Ocular Hypertension; Open Angle Glaucoma
  
• Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis
  ClinicalTrials.gov Identifier: NCT00001213 - Recruiting
  Cystinosis
  
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00527501 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)
  ClinicalTrials.gov Identifier: NCT00485394 - Recruiting
  Age-Related Macular Degeneration
  
• Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
  ClinicalTrials.gov Identifier: NCT00500045 - Recruiting
  Central Retinal Vein Occlusion; Branch Retinal Vein Occlusion
  
• MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
  ClinicalTrials.gov Identifier: NCT00563394 - Completed
  Diabetic Foot Ulcers
  
• MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
  ClinicalTrials.gov Identifier: NCT00563433 - Completed
  Diabetic Foot Ulcers
  
• Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment with Dorzolamide
  ClinicalTrials.gov Identifier: NCT00152932 - Recruiting
  Laser-Doppler Flowmetry
  
• OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00306488 - Recruiting
  Bilateral Geographic Atrophy; Age-Related Macular Degeneration; AMD
  
• A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects with HIV Infection
  ClinicalTrials.gov Identifier: NCT00002249 - Completed
  HIV Infections
  
• Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00079417 - Recruiting
  intraocular retinoblastoma
  
• Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Vs. Placebo in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00135824 - Completed
  healthy subjects
  
• Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes
  ClinicalTrials.gov Identifier: NCT00047554 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• Systemic Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy With or Without Low-Dose Radiation Therapy in Treating Children With Intraocular Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00072384 - Recruiting
  intraocular retinoblastoma
  
• Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
  ClinicalTrials.gov Identifier: NCT00355446 - Completed
  Cataract
  
• Next Generation Ophthalmic Irrigating Solution Posterior Segment Study
  ClinicalTrials.gov Identifier: NCT00333203 - Completed
  Eye Diseases
  
• Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
  ClinicalTrials.gov Identifier: NCT00333268 - Completed
  Cataract
  
• Dose-Response Study of OPC-12759 Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00234078 - Completed
  Dry Eye Syndromes
  
• Fluorophotometry Evaluation of Lubricant Eye Drops
  ClinicalTrials.gov Identifier: NCT00347854 - Completed
  Healthy
  
• Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
  ClinicalTrials.gov Identifier: NCT00413751 - Completed
  Healthy
  
• A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients with Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00061529 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients
  ClinicalTrials.gov Identifier: NCT00352807 - Completed
  Cataract
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
  ClinicalTrials.gov Identifier: NCT00406887 - Completed
  Anterior Uveitis; Panuveitis
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
  ClinicalTrials.gov Identifier: NCT00407056 - Completed
  Uveitis; Panuveitis
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
  ClinicalTrials.gov Identifier: NCT00405496 - Completed
  Anterior Uveitis
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
  ClinicalTrials.gov Identifier: NCT00406497 - Completed
  Inflammation
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
  ClinicalTrials.gov Identifier: NCT00407225 - Completed
  Inflammation
  
• A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00414999 - Completed
  Macular Degeneration; Diabetic Retinopathy
  
• Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation
  ClinicalTrials.gov Identifier: NCT00406341 - Completed
  Inflammation
  
• Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567762 - Completed
  Keratoconjunctivitis; Conjunctivitis
  
• Study of Rebamipide Eye Drops to Treat Dry Eye
  ClinicalTrials.gov Identifier: NCT00201955 - Completed
  Keratoconjunctivitis Sicca
  
• Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma
  ClinicalTrials.gov Identifier: NCT00356720 - Completed
  Trachoma
  
• Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00357383 - Completed
  Eye Infections, Bacterial
  
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
  ClinicalTrials.gov Identifier: NCT00198536 - Completed
  Dry Eye Syndromes
  
• Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00565123 - Completed
  Bacterial Conjunctivitis
  
• New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis
  ClinicalTrials.gov Identifier: NCT00001736 - Completed
  Cystinosis
  
• A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00170729 - Completed
  Cataract Surgery
  
• Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease
  ClinicalTrials.gov Identifier: NCT00403975 - Completed
  Dry Eye Disease
  
• Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
  ClinicalTrials.gov Identifier: NCT00403715 - Completed
  Dry Eye Disease
  
• Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
  ClinicalTrials.gov Identifier: NCT00404131 - Completed
  Dry Eye Disease
  
• Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
  ClinicalTrials.gov Identifier: NCT00010426 - Completed
  Cystinosis
  
• Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00515424 - Completed
  Glaucoma; Ocular Hypertension
  
• Clinical Trial of Eye Prophylaxis in the Newborn
  ClinicalTrials.gov Identifier: NCT00000120 - Completed
  Chlamydia Infections; Ophthalmia Neonatorum
  
• Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00465621 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Safety and Efficacy Comparison Ketotifen Ophthalmic Solution with Emedastine in Patients with Seasonal Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00133627 - Completed
  Seasonal allergic conjunctivitis
  
• A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00134992 - Completed
  Healthy volunteers
  
• Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
  ClinicalTrials.gov Identifier: NCT00335114 - Completed
  Contact Lens Wearers With Dry Eye Syndrome
  
• Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients with Moderate to Severe Keratoconjunctivitis Sicca
  ClinicalTrials.gov Identifier: NCT00128245 - Completed
  Keratoconjunctivitis sicca (dry eye syndrome)
  
• Adherence with Iron Sprinkles Among High-Risk Infants
  ClinicalTrials.gov Identifier: NCT00136266 - Completed
  Anemia; Iron deficiency
  
• Treatment of Dry Eye Syndrome with Cyclosporin A Eye Drops
  ClinicalTrials.gov Identifier: NCT00001731 - Completed
  Keratoconjunctivitis Sicca; Sjogren's Syndrome
  
• Six month clinical research study for patients with moderate or severe dry eye syndrome
  ClinicalTrials.gov Identifier: NCT00025818 - Completed
  Keratoconjunctivitis Sicca; Sjogren's Syndrome; Lupus Erythematosus, Systemic; Arthritis, Rheumatoid; Scleroderma, Systemic